We empower innovative companies to help defend against major health security threats.

Learn More

Exciting new opportunity at DRIVe

The Division of Research, Innovation and Ventures (DRIVe) is seeking entrepreneurial, organized, and collaborative interdisciplinary scientists (GS-14) who are passionate about developing life-saving medical countermeasures.

Join Us

BARDA'S STRATEGIC PLAN

2022 - 2026

Learn More

Healing Lungs is open for abstract submissions.

Apply Now

BARDA announces new partnerships to develop next-gen diagnostics for any respiratory RNA virus.

Learn More

DRIVe funds early stage companies for life saving innovation. Check out our programs below to see current funding opportunities.

Current Open programs

Active programs currently accepting submissions

Healing Lungs

Healing Lungs program page image

Advancing technologies that help patients with acute respiratory distress syndrome (ARDS), oxygenate their blood, without further straining ARDS patients' lungs.

Digital MCMs

Digital MCMs program

Empowering people to respond to infectious disease outbreaks through rapidly deployable digital health tools.

Host-based Diagnostics

Digital MCMs program

Harness a patient's systemic responses to inform on health threats and clinical impact.

Host-directed Therapeutics

Digital MCMs program

Advancing therapies focused on fortifying and restoring balance to the patient's defense mechanisms.

Lab at Home

ReDIRECT

On-demand, at-home detection of biochemical health markers to enable diagnostics and telemedicine services.

ReDIRECT

ReDIRECT

Repurposing commonly available drugs to rapidly treat conditions caused by exposure to chemical agents.

Vaccines on Demand

ReDIRECT

Making vaccines where they're needed when they're needed.

ReBooT

ReDIRECT

Repurposing drugs for biological threats.

Current Active programs

Active programs, but paused for accepting submissions

HI-3

HI-3 program page image

Apply the utility of novel health ecosystems, stakeholder collaborations, and real world to data to maximize clinical impact.

Agnostic Diagnostics

NGS program page image

A diagnostic test to identify any and every pathogen from a single sample.

IMMUNECHIP+

Eantch

Enhance the usability of 3D human tissue models ("tissue chips") as tools for drug development.

Closed programs

Past programs, closed and here for reference

COVID-19 RESPONSE

Covid 19 program page image

Rapid and widely available access to COVID-19 testing in the home setting.

ENACT

ENACT program page image

Interpreting physiological signals for pre- or early symptomatic detection of infection.

BEYOND THE NEEDLE

Beyond the Needle program page image

Develop alternative delivery methods for vaccines and other therapeutics.

DRIVe's IMPACT

We change how the government approaches big health security challenges and threats.

We tackle health security threats by seeking breakthrough devices and technologies.

We model our work on the best practices of the entrepreneurial world.

We use tools and authorities to support new technologies, streamline contracting processes, and launch a network of accelerators.

The team is comprised of scientists and venture entrepreneurs dedicated to identifying threats to health security.